Phase IB/II clinical trial of copanlisib in combination with trastuzumab in pretreated recurrent or metastatic HER2-positive breast cancer
Phase of Trial: Phase I/II
Latest Information Update: 16 Mar 2018
At a glance
- Drugs Copanlisib (Primary) ; Trastuzumab (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 15 Mar 2018 Planned number of patients changed from 25 to 31.
- 16 Aug 2016 Status changed from not yet recruiting to recruiting.
- 07 Mar 2016 New trial record